10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 252 filers reported holding 10X GENOMICS INC in Q2 2022. The put-call ratio across all filers is 0.59 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $388,560 | +31.7% | 10,663 | +2.9% | 0.02% | +19.0% |
| Q3 2022 | $295,000 | -39.3% | 10,363 | -3.4% | 0.02% | -32.3% |
| Q2 2022 | $486,000 | -44.0% | 10,732 | -5.9% | 0.03% | -13.9% |
| Q1 2022 | $868,000 | -53.7% | 11,410 | -9.4% | 0.04% | -41.0% |
| Q4 2021 | $1,876,000 | -12.3% | 12,591 | -14.3% | 0.06% | -15.3% |
| Q3 2021 | $2,139,000 | -13.7% | 14,691 | +16.1% | 0.07% | -13.3% |
| Q2 2021 | $2,478,000 | +6.2% | 12,659 | -1.8% | 0.08% | -7.8% |
| Q1 2021 | $2,333,000 | +18.7% | 12,887 | -7.2% | 0.09% | +4.7% |
| Q4 2020 | $1,966,000 | +40.0% | 13,884 | +23.3% | 0.09% | +19.4% |
| Q3 2020 | $1,404,000 | +513.1% | 11,264 | +338.6% | 0.07% | +453.8% |
| Q2 2020 | $229,000 | – | 2,568 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 2,106,757 | $117,894,122 | 100.00% |
| Blue Water Life Science Advisors, LP | 194,500 | $10,884,220 | 9.53% |
| Sands Capital Ventures, LLC | 481,770 | $26,959,849 | 7.50% |
| Meritech Capital Associates V L.L.C. | 494,236 | $27,657,447 | 6.73% |
| Decheng Capital LLC | 359,554 | $20,120,642 | 5.62% |
| Iron Triangle Partners LP | 479,374 | $26,825,769 | 3.47% |
| Brown Capital Management | 3,527,297 | $197,387,540 | 2.96% |
| Freshford Capital Management, LLC | 305,798 | $17,112,456 | 2.78% |
| SVB WEALTH LLC | 1,446,552 | $80,949,066 | 1.97% |
| Capital Impact Advisors, LLC | 23,594 | $1,320,320 | 1.74% |